Rps Internal Medicine Reading, PA - 19611

Rps Internal Medicine is categorized under Internal Medicine Doctors in Reading, PA and active since 2001.

Rps Internal Medicine was established in 2001, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Donna Majewski, Office Manager at the company’s single location by writing to 301 South 7th Avenue # 340, Reading, Pennsylvania PA 19611 or by phoning (610) 988-8480. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Rps Internal Medicine
Contact Person: Donna Majewski, Office Manager
Address: 301 South 7th Avenue # 340, Reading, Pennsylvania 19611
Phone Number: (610) 988-8480
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Rps Internal Medicine was started in 2001 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Donna Majewski, Office Manager for inquiries that concern Rps Internal Medicine by calling the company number (610) 988-8480, as your correspondence is most welcome. Additionally, the physical location of the single location of Rps Internal Medicine can be found at the coordinates 40.33063,-75.95216 as well as the street address 301 South 7th Avenue # 340 in Reading, Pennsylvania 19611.

For its online presence, you may visit Rps Internal Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.